Akeso's Ivonescimab Cuts Death Risk 34% in ASCO Plenary China Trial
A bispecific antibody from a Chinese biotech beat Keytruda in squamous lung cancer — the first China-origin drug to present at an ASCO plenary session in 61 years.
Kenji Nakamura
Bureau: Tokyo
UN Report Says AI Data Centers Will Use Water Equal to 1.3 Billion People
The UNU study quantifies what carbon-only reporting misses — AI's water footprint will match Sub-Saharan Africa's domestic needs while electricity consumption triples to 945 TWh.
J&J Pays $1 Billion for Firefly Bio Platform That Degrades KRAS Tumors
J&J acquired a protein-degrader platform targeting the 'holy grail' of oncology — and biotech discourse says this could be the next ADC-scale paradigm shift.
Lost Science Claims Meet AI Governance Requirements
Scientific claims require operational translation before they become AI governance policy.